Related Experiment Video
Updated: Jun 19, 2026

Testing Sensory and Multisensory Function in Children with Autism Spectrum Disorder
Published on: April 22, 2015
A Call for More Inclusive, Patient-Centered Nomenclature for Antipsychotics in the Treatment of Autism Spectrum
Julia Totten1, Navneet Kaur1, Nilaksa Sivanenthiran1
1Department of Neurology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.
Abstract:
Risperidone and aripiprazole are US Food and Drug Administration (FDA)-approved to treat irritability and aggression in autism spectrum disorder. This is a time to reflect on whether the terminology of these medications is respectful to this patient population. Misleading terminology can give rise to uncertainty and delay in treatment. Based on past examples of evolving medication nomenclature, we advocate for a change in the language used to describe these medications to improve clarity surrounding treatment and support inclusive and positive care experiences.
Related Concept Videos
Psychosis and Antipsychotic Drugs: Overview
Psychosis: Goals of Pharmacotherapy
Antipsychotic Drugs: Therapeutic Uses and Side Effects
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
Modeling in Therapy
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in situations...
Drug Therapy
Antianxiety Medications
Autism Spectrum Disorder
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.

